Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene

mBio

Volumn 8, Issue 4, 2017, Pages

  Ito, Ryota ^a   Mustapha, Mustapha M ^a   Tomich, Adam D ^a   Callaghan, Jake D ^a   McElheny, Christi L ^a   Mettus, Roberta T ^a   Shanks, Robert M Q ^a   Sluis Cremer, Nicolas ^a   Doi, Yohei ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Fosfomycin resistance; Genomics; Glutathione S transferase; Gram negative; Phylogenetics

Indexed keywords

FOSFOMYCIN; GLUTATHIONE TRANSFERASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BURKHOLDERIA CEPACIA; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FOSA GENE; GENE ACTIVITY; GENE DELETION; GENE LOCATION; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; DRUG EFFECTS; ENTEROBACTERIACEAE; GENETICS; GENOMICS; MICROBIAL SENSITIVITY TEST; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHROMOSOMES, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FOSFOMYCIN; GENOME, BACTERIAL; GENOMICS; GLUTATHIONE TRANSFERASE; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 85029167737     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00749-17     Document Type: Article

References (37)

1. Shoji J, Kato T, Hinoo H, Hattori T, Hirooka K, Matsumoto K, Tanimoto T, Kondo E. 1986. Production of fosfomycin (phosphonomycin) by Pseudomonas syringae. J Antibiot 39:1011–1012. https://doi.org/10.7164/antibiotics.39.1011.
2. Silver LL. 2017. Fosfomycin: mechanism and resistance. Cold Spring Harb Perspect Med 7:a025262. https://doi.org/10.1101/cshperspect.a025262.
3. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America, European Society for Microbiology and Infectious Diseases. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120. https://doi.org/10.1093/cid/ciq257.
4. Vardakas KZ, Legakis NJ, Triarides N, Falagas ME. 2016. Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. Int J Antimicrob Agents 47:269–285. https://doi.org/10.1016/j.ijantimicag.2016.02.001.
5. Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA. 2010. In vitro activity of fosfomycin against blaKPC- containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 54: 526–529. https://doi.org/10.1128/AAC.01235-09.
6. Hirsch EB, Raux BR, Zucchi PC, Kim Y, McCoy C, Kirby JE, Wright SB, Eliopoulos GM. 2015. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. Int J Antimicrob Agents 46:642–647. https://doi.org/10.1016/j.ijantimicag.2015.08.012.
7. Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. 2016. Fosfomycin. Clin Microbiol Rev 29:321–347. https://doi.org/10.1128/CMR.00068-15.
8. Bernat BA, Laughlin LT, Armstrong RN. 1997. Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases. Biochemistry 36:3050–3055. https://doi.org/10.1021/bi963172a.
9. Mendoza C, Garcia JM, Llaneza J, Mendez FJ, Hardisson C, Ortiz JM. 1980. Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob Agents Chemother 18:215–219. https://doi.org/10.1128/AAC.18.2.215.
10. García-Lobo JM, Ortiz JM. 1982. Tn2921, a transposon encoding fosfomycin resistance. J Bacteriol 151:477–479.
11. Guo Q, Tomich AD, McElheny CL, Cooper VS, Stoesser N, Wang M, Sluis-Cremer N, Doi Y. 2016. Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. J Antimicrob Chemother 71:2460–2465. https://doi.org/10.1093/jac/dkw177.
12. Ma Y, Xu X, Guo Q, Wang P, Wang W, Wang M. 2015. Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol 60:259–264. https://doi.org/10.1111/lam.12366.
13. Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. 2010. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother 54: 3061–3064. https://doi.org/10.1128/AAC.01834-09.
14. Ho PL, Chan J, Lo WU, Lai EL, Cheung YY, Lau TC, Chow KH. 2013. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62:1707–1713. https://doi.org/10.1099/jmm.0.062653-0.
15. Jiang Y, Shen P, Wei Z, Liu L, He F, Shi K, Wang Y, Wang H, Yu Y. 2015. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. Int J Antimicrob Agents 45:66–70. https://doi.org/10.1016/j.ijantimicag.2014.08.010.
16. Diene SM, Merhej V, Henry M, El Filali A, Roux V, Robert C, Azza S, Gavory F, Barbe V, La Scola B, Raoult D, Rolain JM. 2013. The rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new “killer bugs” are created because of a sympatric lifestyle. Mol Biol Evol 30:369–383. https://doi.org/10.1093/molbev/mss236.
17. Rife CL, Pharris RE, Newcomer ME, Armstrong RN. 2002. Crystal structure of a genomically encoded fosfomycin resistance protein (FosA) at 1.19 A resolution by MAD phasing off the L-III edge of Tl(+). J Am Chem Soc 124:11001–11003. https://doi.org/10.1021/ja026879v.
18. Clinical and Laboratory Standards Institute. 2017. Performance standards for antimicrobial susceptibility testing, 27th ed. M100-S27. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. 2010. Fosfomycin for the treatment of multidrug-resistant, including extendedspectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10:43–50. https://doi.org/10.1016/S1473-3099(09)70325-1.
20. Sastry S, Doi Y. 2016. Fosfomycin: resurgence of an old companion. J Infect Chemother 22:273–280. https://doi.org/10.1016/j.jiac.2016.01.010.
21. Xu H, Miao V, Kwong W, Xia R, Davies J. 2011. Identification of a novel fosfomycin resistance gene (fosA2) in Enterobacter cloacae from the Salmon River, Canada. Lett Appl Microbiol 52:427–429. https://doi.org/10.1111/j.1472-765X.2011.03016.x.
22. Chislett RJ, White G, Hills T, Turner DP. 2010. Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK. J Antimicrob Chemother 65:1076–1077. https://doi.org/10.1093/jac/dkq051.
23. Hsu MS, Liao CH, Liu CY, Yang CJ, Huang YT, Hsueh PR. 2011. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents. Int J Antimicrob Agents 37:276–278. https://doi.org/10.1016/j.ijantimicag.2010.12.003.
24. Grabein B, Graninger W, Rodríguez Baño J, Dinh A, Liesenfeld DB. 2017. Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature. Clin Microbiol Infect 23:363–372. https://doi.org/10.1016/j.cmi.2016.12.005.
25. Parker SL, Frantzeskaki F, Wallis SC, Diakaki C, Giamarellou H, Koulenti D, Karaiskos I, Lipman J, Dimopoulos G, Roberts JA. 2015. Population pharmacokinetics of fosfomycin in critically ill patients. Antimicrob Agents Chemother 59:6471–6476. https://doi.org/10.1128/AAC.01321-15.
26. León J, García-Lobo JM, Navas J, Ortiz JM. 1985. Fosfomycin-resistance plasmids determine an intracellular modification of fosfomycin. J Gen Microbiol 131:1649–1655. https://doi.org/10.1099/00221287-131-7-1649.
27. Rehman MA, Yin X, Persaud-Lachhman MG, Diarra MS. 2017. First detection of a fosfomycin resistance gene, fosA7, in Salmonella enterica serovar Heidelberg isolated from broiler chickens. Antimicrob Agents Chemother 61:e00410-17. https://doi.org/10.1128/AAC.00410-17.
28. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. https://doi.org/10.1093/jac/dks261.
29. Katoh K, Standley DM. 2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30:772–780. https://doi.org/10.1093/molbev/mst010.
30. Whelan S, Goldman N. 2001. A general empirical model of protein evolution derived from multiple protein families using a maximumlikelihood approach. Mol Biol Evol 18:691–699. https://doi.org/10.1093/oxfordjournals.molbev.a003851.
31. Kumar S, Stecher G, Tamura K. 2016. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol 33: 1870–1874. https://doi.org/10.1093/molbev/msw054.
32. Letunic I, Bork P. 2016. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 44:W242–W245. https://doi.org/10.1093/nar/gkw290.
33. Shanks RM, Stella NA, Hunt KM, Brothers KM, Zhang L, Thibodeau PH. 2015. Identification of SlpB, a cytotoxic protease from Serratia marcescens. Infect Immun 83:2907–2916. https://doi.org/10.1128/IAI.03096-14.
34. Shanks RM, Caiazza NC, Hinsa SM, Toutain CM, O’Toole GA. 2006. Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol 72:5027–5036. https://doi.org/10.1128/AEM.00682-06.
35. Shanks RM, Kadouri DE, MacEachran DP, O’Toole GA. 2009. New yeast recombineering tools for bacteria. Plasmid 62:88–97. https://doi.org/10.1016/j.plasmid.2009.05.002.
36. Nakamura G, Wachino J, Sato N, Kimura K, Yamada K, Jin W, Shibayama K, Yagi T, Kawamura K, Arakawa Y. 2014. Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases. J Clin Microbiol 52:3175–3179. https://doi.org/10.1128/JCM.01094-14.
37. Navas J, León J, Arroyo M, García Lobo JM. 1990. Nucleotide sequence and intracellular location of the product of the fosfomycin resistance gene from transposon Tn2921. Antimicrob Agents Chemother 34: 2016–2018. https://doi.org/10.1128/AAC.34.10.2016.